Johnson & Johnson Competitors and Similar CompaniesClear all
Johnson & Johnson's competitors and similar companies include Reckitt Benckiser, GSK, Medtronic, Roche, Abbott, Novartis, Bayer, Pfizer, Procter & Gamble and Unilever.
 Johnson & Johnson Johnson & Johnson (J&J) is a company that engages in the research and development, manufacture, and sale of a range of products in the healthcare field. |  Reckitt Benckiser Reckitt Benckiser Group is a company that manufactures and sells health, hygiene, and nutrition products. |  GSK GSK (GlaxoSmithKline) is a science-led healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. |  Abbott Abbott Laboratories is a company that specializes in the discovery, development, manufacture, and sale of healthcare products. |  Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products. |  Pfizer Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products. |  Procter & Gamble Procter & Gamble (P&G) is a company that provides personal care products, cleaning agents, and other consumer goods. | |||||
Founding Date | Founding Date 1886 | Founding Date 1823 | Founding Date 2000 | Founding Date 1949 | Founding Date 1896 | Founding Date 1888 | Founding Date 1996 | Founding Date 1863 | Founding Date 1849 | Founding Date 1837 | Founding Date 1894 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||||||||
Locations | Locations New Brunswick, US HQ Buenos Aires, AR Sydney, AU Vienna, AT Minsk, BY Beerse, BE Sofia, BG see more | Locations Slough, GB HQ Buenos Aires, AR Sydney, AU Wien, AT Anderlecht, BE Sarajevo, BA Sao Paulo, BR see more | Locations London, GB HQ Boumerdes, DZ Buenos Aires, AR Abbotsford, AU Wien, AT Wavre, BE Rio De Janeiro, BR see more | Locations Galway, IE HQ Buenos Aires, AR Macquarie Park, AU Wien, AT Dhaka, BD Jette, BE Monções, BR see more | Locations Abbott Park, US HQ Tiranë, AL Buenos Aires, AR Yerevan, AM Doncaster, AU East Brisbane, AU Macquarie Park, AU see more | Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more | Locations New York, US HQ Buenos Aires, AR Villa Adelina, AR Footscray, AU Mulgrave, AU Sydney, AU Wien, AT see more | Locations Cincinnati, US HQ Buenos Aires, AR Sydney, AU Minsk, BY Grimbergen, BE Ilidža, BA Sao Paulo, BR see more | |||
Employees | Employees 138,1005% increase | Employees 37,900 | Employees 68,629 | Employees 95,000 | Employees 103,249 | Employees 114,000 | Employees 75,883 | Employees 88,5021% decrease | Employees 81,0008% decrease | Employees 109,0002% increase | Employees 115,964 |
Valuation ($) | Valuation ($) 396.3 b | Valuation ($) 396.3 m | Valuation ($) 862.5 m | Valuation ($) 114.6 b | Valuation ($) N/A | Valuation ($) 196.1 b | Valuation ($) N/A | Valuation ($) 27.1 b | Valuation ($) 163.9 b | Valuation ($) 401 b | Valuation ($) 1.6 b |
Financial | |||||||||||
Revenue (est.) | Revenue (est.) $94.2b (FY, 2025) | Revenue (est.) £14.2b (FY, 2025) | Revenue (est.) £32.7b (FY, 2025) | Revenue (est.) $33.5b (FY, 2025) | Revenue (est.) CHF61.5b (FY, 2025) | Revenue (est.) $44.3b (FY, 2025) | Revenue (est.) $56.7b (FY, 2025) | Revenue (est.) €45.6b (FY, 2025) | Revenue (est.) $62.6b (FY, 2025) | Revenue (est.) $84.3b (FY, 2025) | Revenue (est.) €58.2b (FY, 2025) |
Cost of goods | Cost of goods $30.3b (FY, 2025) | Cost of goods £5.1b (FY, 2025) | Cost of goods £5.6b (FY, 2025) | Cost of goods $11.6b (FY, 2025) | Cost of goods CHF13.1b (FY, 2025) | Cost of goods $19.3b (FY, 2025) | Cost of goods $8.4b (FY, 2025) | Cost of goods €14b (FY, 2025) | Cost of goods $16.1b (FY, 2025) | Cost of goods $41.2b (FY, 2025) | Cost of goods €29.8b (FY, 2025) |
Gross profit | Gross profit $63.9b (FY, 2025) | Gross profit £10.4b (FY, 2025) | Gross profit £28.5b (FY, 2025) | Gross profit $21.9b (FY, 2025) | Gross profit CHF50.5b (FY, 2025) | Gross profit $25b (FY, 2025) | Gross profit $49.8b (FY, 2025) | Gross profit €32.5b (FY, 2025) | Gross profit $46.5b (FY, 2025) | Gross profit $43.1b (FY, 2025) | Gross profit €28.4b (FY, 2025) |
Net income | Net income $26.8b (FY, 2025) | Net income £3.2b (FY, 2025) | Net income £6.3b (FY, 2025) | Net income $4.7b (FY, 2025) | Net income CHF13.8b (FY, 2025) | Net income $6.5b (FY, 2025) | Net income $14b (FY, 2025) | Net income (€3.6b) (FY, 2025) | Net income $7.8b (FY, 2025) | Net income $16.1b (FY, 2025) | Net income €6.6b (FY, 2025) |
Operating ⚠ | |||||||||||
Countries | Countries N/A | Countries N/A | Countries 92 (FY, 2021) | Countries 150 (FY, 2025) | Countries N/A | Countries N/A | Countries N/A | Countries 83 (FY, 2021) | Countries 200 (FY, 2024) | Countries 180 (FY, 2023) | Countries 190 (FY, 2023) |
Manufacturing Facilities (United States) | Manufacturing Facilities (United States) 28 (FY, 2022) | Manufacturing Facilities (United States) N/A | Manufacturing Facilities (United States) N/A | Manufacturing Facilities (United States) N/A | Manufacturing Facilities (United States) N/A | Manufacturing Facilities (United States) N/A | Manufacturing Facilities (United States) N/A | Manufacturing Facilities (United States) N/A | Manufacturing Facilities (United States) N/A | Manufacturing Facilities (United States) 24 (FY, 2023) | Manufacturing Facilities (United States) N/A |
Patients | Patients N/A | Patients N/A | Patients N/A | Patients 79 m (FY, 2025) | Patients 22.8 m (FY, 2023) | Patients N/A | Patients 10 m (FY, 2022) | Patients N/A | Patients N/A | Patients N/A | Patients N/A |
Phase I Trials Products | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products 16 (FY, 2021) | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products 51 (FY, 2024) | Phase I Trials Products N/A | Phase I Trials Products N/A |
Phase II Trials Products | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products 6 (FY, 2021) | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products 27 (FY, 2024) | Phase II Trials Products N/A | Phase II Trials Products N/A |
Phase III Trials Products | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products 11 (FY, 2021) | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products 44 (FY, 2022) | Phase III Trials Products N/A | Phase III Trials Products 32 (FY, 2024) | Phase III Trials Products N/A | Phase III Trials Products N/A |
Registration Phase Products | Registration Phase Products N/A | Registration Phase Products N/A | Registration Phase Products N/A | Registration Phase Products N/A | Registration Phase Products N/A | Registration Phase Products N/A | Registration Phase Products 8 (FY, 2022) | Registration Phase Products N/A | Registration Phase Products 5 (FY, 2024) | Registration Phase Products N/A | Registration Phase Products N/A |
Suppliers | Suppliers N/A | Suppliers N/A | Suppliers 37.5 k (FY, 2021) | Suppliers N/A | Suppliers N/A | Suppliers N/A | Suppliers N/A | Suppliers 93.8 k (FY, 2021) | Suppliers N/A | Suppliers N/A | Suppliers N/A |
Funding | |||||||||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 340.8m | Total funding raised $ 7.8b | Total funding raised N/A | Total funding raised $ 6.5m | Total funding raised $ 3.5b | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Reckitt Benckiser
HQ
Slough, GB
Employees
37,900
Reckitt Benckiser Group is a company that manufactures and sells health, hygiene, and nutrition products.
View companyGSK
HQ
London, GB
Employees
68,629
GSK (GlaxoSmithKline) is a science-led healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products.
View company
Medtronic
HQ
Galway, IE
Employees
95,000
Medtronic is a company that specializes in healthcare technologies and therapies.
View company
Roche
HQ
Basel, CH
Employees
103,249
Roche Holding is a biotech company that provides in vitro diagnostics and supplies services.
View company